Evidence map›Paper›PMID 39672391›Full record

ArticleMatrix biology : journal of the International Society for Matrix Biology2025

Cleavage of Cartilage Oligomeric Matrix Protein (COMP) by ADAMTS4 generates a neoepitope associated with osteoarthritis and other forms of degenerative joint disease.

Rens de Groot, Patricia Badía Folgado, Kazuhiro Yamamoto, Daniel R Martin, Christopher D Koch, Danielle Debruin, Sophie Blagg, Alexander F Minns, Sumit Bhutada, Josefin Ahnström and 5 more

Abstract read
In one paragraph

Article in Matrix biology : journal of the International Society for Matrix Biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Rens de GrootInstitute of Cardiovascular Science, University College London, 51 Chenies Mews, London WC1E 6HX, United Kingdom. Electronic address: r.degroot@ucl.ac.uk.
Patricia Badía FolgadoDepartment of Immunology and Inflammation, Imperial College London, Du Cane Road, London W12 0NN, United Kingdom.
Kazuhiro YamamotoInstitute of Life Course and Medical Sciences, Faculty of Health and Life Sciences, University of Liverpool, 6 West Derby Street, Liverpool L7 8TX, United Kingdom.
Daniel R MartinDepartment of Biomedical Engineering, Cleveland Clinic Lerner Research Institute, Cleveland, OH 44195, USA.
Christopher D KochDepartment of Biomedical Engineering, Cleveland Clinic Lerner Research Institute, Cleveland, OH 44195, USA.
Danielle DebruinDepartment of Biochemical Sciences, School of Biosciences, Faculty of Health and Medical Sciences, Edward Jenner Building, University of Surrey, Guildford, Surrey GU2 7XH, United Kingdom.
Sophie BlaggDepartment of Immunology and Inflammation, Imperial College London, Du Cane Road, London W12 0NN, United Kingdom.
Alexander F MinnsDepartment of Biochemical Sciences, School of Biosciences, Faculty of Health and Medical Sciences, Edward Jenner Building, University of Surrey, Guildford, Surrey GU2 7XH, United Kingdom.
Sumit BhutadaDepartment of Biomedical Engineering, Cleveland Clinic Lerner Research Institute, Cleveland, OH 44195, USA.
Josefin AhnströmDepartment of Immunology and Inflammation, Imperial College London, Du Cane Road, London W12 0NN, United Kingdom.
Jonathan LarkinSynOA Therapeutics, Philadelphia, PA, USA; Research Unit of Health Sciences and Technology, Faculty of Medicine, University of Oulu, Oulu, Finland.
Anders AspbergRheumatology and Molecular Skeletal Biology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Patrik ÖnnerfjordRheumatology and Molecular Skeletal Biology, Department of Clinical Sciences Lund, Lund University, Lund, Sweden.
Suneel S ApteDepartment of Biomedical Engineering, Cleveland Clinic Lerner Research Institute, Cleveland, OH 44195, USA.
Salvatore SantamariaDepartment of Immunology and Inflammation, Imperial College London, Du Cane Road, London W12 0NN, United Kingdom; Department of Biochemical Sciences, School of Biosciences, Faculty of Health and Medical Sciences, Edward Jenner Building, University of Surrey, Guildford, Surrey GU2 7XH, United Kingdom. Electronic address: s.santamaria@surrey.ac.uk.

Funding

High-End Instrumentation (HEI) Grant Program (S10)S10OD023436 · OD · CLEVELAND CLINIC LERNER COM-CWRU · PI WILLARD, BELINDA BELLE · 2017 to 2017
$873k
The proteolytic landscape of osteoarthritic cartilageR21AR078498 · NIAMS · CLEVELAND CLINIC LERNER COM-CWRU · PI APTE, SUNEEL S · 2022 to 2023
$390k
NIAMS NIH HHS R21 AR078498NIH HHS S10 OD023436Wellcome Trust
6 · The paper itself

Abstract

Osteoarthritis (OA) is a highly prevalent joint disease, affecting millions of people worldwide and characterized by degradation of articular cartilage, subchondral bone remodeling and low-grade inflammation, leading to pain, stiffness and disability. Cartilage Oligomeric Matrix Protein (COMP) is a major structural component of cartilage and its degradation has been proposed as a marker of OA severity/progression. Several proteases cleave COMP in vitro, however, it is unclear which of these COMPase activities is prevalent in an osteoarthritic joint. Here, using purified recombinant proteins, we show that A Disintegrin And Metalloproteinase with Thrombospondin motifs 4 (ADAMTS4) is the most potent COMPase, followed by ADAMTS1. Using liquid chromatography-tandem mass spectrometry, we identified several novel cleavage sites in COMP resulting from ADAMTS4 and ADAMTS1 activity. Cleavage at S

Indexed as

ADAMTS4 ProteinCartilage Oligomeric Matrix ProteinEpitopesOsteoarthritisADAMTS1 ProteinCartilage, ArticularHumansProcollagen N-EndopeptidaseProteolysisADAMTS1 ProteinADAMTS1 protein, humanADAMTS4 ProteinADAMTS4 protein, humanCartilage Oligomeric Matrix ProteinEpitopesProcollagen N-EndopeptidaseTSP5 protein, humanADAMTSADAMTS4BiomarkerCartilage oligomeric matrix proteinExtracellular matrixNeoepitopeOsteoarthritisProteolysis

Identifiers

PMID39672391
PMCPMC12342048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.